Trade

Sakar Healthcare share price

  • NaN%Low risk
  • NaN%Moderate risk
  • NaN%Balanced risk
  • NaN%High risk
  • NaN%Extreme risk
  • 352.85(0.76%)
    July 9, 2025 15:29:55 PM IST
    • NSE
    • BSE
  • Vol : 11.24K (NSE + BSE)
    Last 20 day avg : 56.04 K

Sakar Healthcare is trading 0.76% upper at Rs 352.85 as compared to its last closing price. Sakar Healthcare has been trading in the price range of 358.45 & 345.00. Sakar Healthcare has given 18.57% in this year & 0.59% in the last 5 days. Sakar Healthcare has TTM P/E ratio 26.47 as compared to the sector P/E of 22.94.The company posted a net profit of 5.76 Crores in its last quarter.Listed peers of Sakar Healthcare include Kopran (-0.22%), Tembo Global Industries (-1.37%), Sakar Healthcare (0.76%).The Mutual Fund holding in Sakar Healthcare was at -% in . The MF holding has - from the last quarter. The FII holding in Sakar Healthcare was at 13.60% in 31 Mar 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Key Metrics

Updated on Jul 10, 2025, 01:55 AM UTC

  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    2.65
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    43.61
    Higher than historical values
  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.83
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.30
    Higher than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -
Price range
Day Range
Lowest
345.00
Highest
358.45
52 week range
Lowest
210.10
Highest
380.80
Sakar Healthcare Financials
Financials
Financials include key reports like the Profit & Loss Statement (P&L), Balance Sheet, and Cash Flow Statement, providing insights into a company's performance, financial health, and liquidity
View all
  • Income
  • Balance Sheet
  • Cash Flow
Loading...
Units in the chart are in crores
Insights
  • Financial
  • Valuation
    No Data
    Financial insights for Sakar Healthcare are currently unavailable
    Please check back later.
Sakar Healthcare Technical Analysis
Pivot Level - classic
Info
Key price levels (support and resistance) calculated using the previous day's high, low, and close, aiding in technical analysis and trading decisions
  • R1
  • 370.10
  • R2
  • 387.55
  • R3
  • 405.10
Pivot352.55
  • S1
  • 335.10
  • S2
  • 317.55
  • S3
  • 300.10
Short Term
Info
Considers price movement over the last 1-2 weeks
Not Available
Long Term
Info
Considers price movement over the last 6 months
Not Available
  • Very Bearish
  • Bearish
  • Neutral
  • Very Bullish
  • Bullish
Trends unavailable at the moment.
Sakar Healthcare Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Kopran
Bearish
178.60-0.22862.8622.761.691.653.18
Tembo Global Industries
Neutral
514.00-1.371,297.5917.096.360.5617.91
Sakar Healthcare
Bullish
352.850.76785.0943.562.64-18.77
Ngl Fine-chem
Moderately Bullish
1,270.001.52784.6135.392.650.148.97
Kilitch Drugs India
Neutral
415.50-1.78668.3026.733.53-13.73
Sakar Healthcare Shareholding
View All
Shareholding Pattern
Breakdown of a company's ownership structure, showing stakes held by Promoters, Mutual Funds, FII(s) & Others.
    No Data
    Shareholding pattern for Sakar Healthcare is currently unavailable
    Please check back later.
    Shareholding Insights
    • InsightsPromoter(s) holds a high stake in the company at 53.58%
    • InsightsPromoter(s) have increased the stake in the company in last 12 months
    • InsightsFIIs are invested in this company
    • InsightsFIIs holding has increased by 0.03 percentage points from previous quarter
    • InsightsMutual Funds are not invested in this company.
    Sakar Healthcare Corporate Actions
    View all
    • Board Meetings
    • AGM
    • Dividends
    • Bonus
    • Split
    • Rights
    Meeting DatePurpose
    2025-05-15Audited results
    2025-02-08Quarterly Results
    2024-10-22Quarterly Results
    2024-08-13Quarterly Results
    2024-05-21Audited results
    About the company Sakar Healthcare
    • IndustryBiotechnology & Drugs
    • ISININE732S01012
    • BSE Code
    • NSE CodeSAKAR
    Sakar Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical products providing liquid orals, cephalosporin tablets, capsules, dry powder syrup, dry powder injections, liquid injectables (SVP) in ampoules and vials & lyophilized injections. The Company's oncology products include oral solid dosage (tablet & capsule), liquid injection, lyophilized injection, active pharmaceutical ingredient (API), CDMO products and CRAMs. It has a presence across the regions of Africa (Anglo & Francophone), SEASIA, CIS, Latin & Central America and in Europe. It operates in over 50 countries globally and has approximately 292 registered products. It exports to Southeast Asia, Asia, Africa-Anglo & Francophone, MENA, America, covering around 38 countries with more than 250 brands registered.
    • Management Info
    • Sanjay ShahChairman of the Board, Managing Director
    • Dharmesh ThakerChief Financial Officer
    • Bharat SoniCompliance Officer, Company Secretary
    • Aarsh ShahJoint Managing Director, Director
    • Sunil MaratheWhole Time Director - Technical
    Sakar Healthcare Share Price FAQs

    Sakar Healthcare is trading at 352.85 as on Wed Jul 09 2025 09:59:55. This is 0.76% upper as compared to its previous closing price of 350.20.

    The market capitalization of Sakar Healthcare is 785.09 Cr as on Wed Jul 09 2025 09:59:55.

    The 52 wk high for Sakar Healthcare is 380.80 whereas the 52 wk low is 210.10

    Sakar Healthcare can be analyzed on the following key metrics -

    • TTM P/E: 26.47
    • Sector P/E: 22.94
    • Dividend Yield: 0.00%
    • D/E ratio: 0.30

    Sakar Healthcare reported a net profit of 17.50 Cr in 2025.